ASX uranium stocks surged after Nvidia CEO Jensen Huang appeared on The Joe Rogan Experience and made a bold prediction about AI's future. He declared that nuclear power is "the smartest way" to solve AI's growing energy crisis. He also predicted that tech giants will soon build their own small nuclear reactors because the existing…
Just months ago, investors were betting on rate cuts to ease pressure on borrowers. That narrative has shifted dramatically. Inflation in Australia rose to 3.8% in October, above the RBA’s target of 2–3%. As a result, markets now see a 70% chance of at least one rate hike before the end of 2026. The RBA…
Centuria Industrial REIT's Latest Distribution
Centuria Industrial REIT (ASX: CIP) has announced a distribution of 4.2 cents per unit for the quarter ending December 31. What caught our attention isn't just the steady payout; it's the context around it. The REIT has kept its distribution reinvestment plan (DRP) suspended while running an active buyback program.…
Introduction to Battery-Electric Haul Trucks
Australia's first battery-electric haul trucks have arrived in the Pilbara, marking a significant milestone in the mining industry's push to eliminate diesel from iron ore operations. BHP (ASX: BHP) and Rio Tinto (ASX: RIO) are collaborating with Caterpillar to trial two Cat 793 XE Early Learner trucks at BHP's Jimblebar…
Capital Raise to Fund Aggressive Drilling
FireFly Metals (ASX: FFM) shares pulled back this week after the company announced a major capital raise. FireFly secured commitments for approximately A$134.1 million and is seeking a further A$5 million via a share purchase plan, bringing the total raise to around A$139 million. The institutional placement was priced…
The tables have turned, and shareholders face a key decision as the 10 December deadline approaches.
Mayne Pharma (ASX: MYX) has turned the tables on US suitor Cosette Pharmaceuticals, issuing a termination notice alleging "wilful and intentional" breaches of their A$672 million takeover agreement. The Adelaide-based company, which spent much of 2025 fighting Cosette's attempts…
Nuix bets on graph intelligence to rebuild investor confidence after a tough year.
Nuix (ASX: NXL) has agreed to acquire French graph-intelligence company Linkurious SAS in a deal worth up to A$35.4 million. For a company whose shares have fallen more than 70 per cent this year, this acquisition could mark a turning point.
Shares rose…
With copper up 30% this year and supply struggling to keep pace, we break down which ASX stocks offer the best risk-reward.
Copper prices smashed through all-time highs this week, surging past US$11,400 per tonne on the London Metal Exchange. The metal has gained over 30% in 2025, driven by supply fears and unstoppable demand…
Saluda Medical (ASX:SLD) listed on Friday after raising AU$230 million at AU$2.65 per share, marking a rare bright spot in an otherwise quiet year for ASX biotech debuts. Unlike most life sciences IPOs that arrive with little more than clinical-stage promise, Saluda Medical already generates US$70 million in annual revenue and is targeting US$82 million…
Optiscan Imaging (ASX: OIL) has partnered with Australian Clinical Labs to launch Australia's first-in-human head and neck cancer imaging study. The ground-breaking study will recruit 50 patients at the St John of God Healthcare campus in Murdoch and will be led by prominent Perth head and neck cancer surgeon Dr Chady Sader. For investors tracking…
